Advances in Cancer Research, Volume 142, the latest release in this ongoing, well-regarded serial, provides invaluable information on the exciting and fast-moving field of cancer research.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Chapter One: Highly variant DNA methylation in normal tissues identifies a distinct subclass of cancer patients - p. ix 7. Chapter Two: Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations - p. 22 8. Chapter Three: The second genome: Effects of the mitochondrial genome on cancer progression - p. 62 9. Chapter Four: Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors - p. 105 10. Chapter Five: HVEM network signaling in cancer - p. 143 11. Chapter Six: Pharmacology of ME-344, a novel cytotoxic isoflavone - p. 186
Advances in Cancer Research, Volume 142, the latest release in this ongoing, well-regarded serial, provides invaluable information on the exciting and fast-moving field of cancer research.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Chapter One: Highly variant DNA methylation in normal tissues identifies a distinct subclass of cancer patients - p. ix 7. Chapter Two: Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations - p. 22 8. Chapter Three: The second genome: Effects of the mitochondrial genome on cancer progression - p. 62 9. Chapter Four: Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors - p. 105 10. Chapter Five: HVEM network signaling in cancer - p. 143 11. Chapter Six: Pharmacology of ME-344, a novel cytotoxic isoflavone - p. 186
